Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation

International Journal of Pharmaceutics

Volumn 235, Issue 1-2, 2002, Pages 1-15

  Yang, Libo ^a   Chu, James S ^a   Fix, Joseph A ^a  

^a Yamanouchi Shaklee Pharma   (United States)

Author keywords

Colon targeting; Colon specific drug delivery; Microflora; Polysaccharides

Indexed keywords

AZO COMPOUND; CALCIUM DERIVATIVE; CALCIUM PECTINATE; CODES; DEXAMETHASONE; DEXAMETHASONE DERIVATIVE; DRUG CARRIER; ETHYL CELLULOSE; EUDRAGIT; GALACTOMANNAN; INDOMETACIN; PARACETAMOL; PECTIN; POLYMER; POLYSACCHARIDE; PRODRUG; UNCLASSIFIED DRUG; WATER;

ACCURACY; ANIMAL EXPERIMENT; COLON; CONTROLLED DRUG RELEASE; DRUG ACTIVATION; DRUG CAPSULE; DRUG COATING; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG MANUFACTURE; DRUG SCREENING; DRUG SOLUBILITY; DRUG SPECIFICITY; ENTERIC COATED TABLET; FEASIBILITY STUDY; GAMMA SCINTIGRAPHY; HUMAN; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE PRESSURE; KINETICS; METHODOLOGY; MICROFLORA; NONHUMAN; PH; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SUPPOSITORY; TABLET; TARGET ORGAN;

ANIMALS; CAPSULES; COLON; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; HUMANS; HYDROGELS; TABLETS;

EID: 0037139415     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00004-2     Document Type: Review

References (72)

1. Novel pH-sensitive hydrogels with adjustable swelling kinetics
2. A profile scanning method of studying the release properties of different types of tablets in man
3. Colonic absorption of human calcitonin in man
4. Oral colon-specific drug delivery using amylose-based film coatings
5. Manometric investigation of high-amplitude propagated contractile activity of the human colon
6. Hydrogels for site-specific oral drug delivery: Synthesis and characterization
7. Hydrogels for site-specific drug delivery to the colon: In vitro and in vivo degradation
8. Method for minitoring hard gelatin capsule disintegration times in human using external scintigraphy
9. Transit of pharmaceutical dosage forms through the small intestine
10. Gastrointestinal transit of a matrix tablet formulation: Comparison of canine and human data
11. Capacity of the human colon to absorb fluid
12. Gamma scintigraphy and neutron activation techniques in the in vivo assessment of orally administered dosage forms
13. Inflammatory bowel disease
14. Polysaccharide breakdown by mixed populations of human faecal bacteria
15. Oral controlled release technology for peptides: Status and future prospects
16. Colon-specific drug delivery
17. Relative antiinflammatory effect of oral dexamathasone-ß-D-glucoside and dexamathasone in experimental inflammatory bowel disease
18. Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting
19. Development and validation of a pig model for colon-specific drug delivery
20. In vitro degradation of pH-sensitive hydrogels containing aromatic azo bonds
21. Intestinal flora
22. Intestinal bacteria and the hydrolysis of glycosidic bonds
23. Stool water content and colonic drug absorption: Contrasting effects of lactulose and codeine
24. New preparation method of intestinal pressure-controlled colon delivery capsules by coating machine and evaluation in beagle dogs
25. Characterization of norfloxacine release from tablets coated with a new pH-sensitive polymer, P-4135F
26. Colon delivery efficiencies of intestinal pressure-controlled colon delivery capsules prepared by a coating machine in human subjects
27. Application of a biomagnetic measurement system (BMS) to the evaluation of gastrointestinal transit of intestinal pressure-controlled colon delivery capsules (PCDCs) in human subjects
28. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid
29. Comparison of the gastrointestinal anatomy, physiology and biochemistry of human and commonly used laboratory animals
30. Colon-specific drug delivery system (CODES)
31. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation of drug release using Eudragit L100-55 and Eudragit S100 combinations
32. Colonic drug targeting
33. Polymers for colon-specific drug delivery
34. Macromolecular prodrugs. XVI. Colon-targeted delivery - Comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract
35. Synthesis and evaluation of compounds that facilitate the gastrointestinal absorption of heparin
36. The colonic flora, fermentation, and large bowel digestive function
37. Development of a five-step multichamber reactor as a simulation of the human intestinal microbial ecosystem
38. The colon as a site for drug delivery
39. Imaging techniques for assessing drug delivery in man
40. Pharmacoscintigraphic and pharmacokinetic evaluation of colon specific delivery system in healthy volunteers
41. Unconventional dissolution methodologies
42. Ambulatory 24-h colonic manometry in healthy humans
43. Colonic motility and transit in health and ulcerative colitis
44. First-pass metabolism within the lumen of the gastrointestinal tract
45. Approaches and opportunities in colon-specific drug delivery
46. Colonic drug delivery enhanced release of indomethacin from cross-linked chondroitin matrix in rat caecal contents
47. In vitro evaluation of calcium pectinate: A potential colon-specific drug delivery carrier
48. A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis
49. A new approach to the oral administration of insulin and other peptide drugs
50. Oral insulin in diabetic dogs
51. Carbohydrate metabolism in the human colon
52. Polymers for colon specific drug delivery
53. Application of pressure-controlled colon delivery capsule to oral administration of glycyrrhizin in dogs
54. The use of pharmacoscintigraphy to focus the development for a novel 5-ASA colon targeting system ('TIME CLOCK®' system)
55. Development of a colon delivery capsule and the pharmacological activity of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in beagle dogs
56. Human Gastrointestinal transit study of a novel colon delivery system (CODES™) using γ-scintigraphy
57. Spray-dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry-coated tablet having a time-controlled releasing function
58. Enhanced absorption of Insulin and (Asu1,7)Eel-calcitonin using novel azaopolymer-coated pellets for colon-specific drug delivery
59. In vivo evaluation of a colon-specific drug delivery system: An absorption study of theophylline from capsules coated with azo polymers in rats
60. Transit through the proximal colon influences stool weight in the irritable bowel syndrome
61. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea
62. Pectin/ethycellulose film coating formulations for colonic drug delivery
63. Carrageenan-induced ulceration of large intestine in the guinea pig
64. Evidence for the mixing of residue in the human
65. Scintigraphic evaluation of colonic delivery systems
66. The role of γ-scintigraphy in oral drug delivery
67. USP Dissolution Apparatus III (reciprocating cylinder) for screening of guar-based colonic delivery formulations
68. Design and in vitro/in vivo evaluation of a novel colon-specific drug delivery system (CODES™)
69. Biodegradable and pH-sensitive hydrogels: Synthesis by cross-linking of N,N-dimethacrylamide copolymer precursors
70. Site specific drug delivery and penetration enhancement in the gastrointestinal tract